Contents

Current Vascular Pharmacology, Volume 1 - Number 2

Is Impaired Flow-Mediated Dilatation of the Brachial Artery a Cardiovascular Risk Factor?

, 1(2): 107 - 109

Stefan Agewall


DOI: 10.2174/1570161033476745




Endothelial Therapy of Atherosclerosis and its Risk Factors

, 1(2): 111 - 121

Tobias Traupe, Jana Ortmann, Klaus Munter and Matthias Barton


DOI: 10.2174/1570161033476763




Nitric Oxide-Mediated Endothelial Dysfunction - Is there Need to Treat?

, 1(2): 123 - 133

C. P. Tiefenbacher and J. Kreuzer


DOI: 10.2174/1570161033476718




Natural Phenolic Compounds as Cardiovascular Therapeutics: Potential Role of their Antiinflammatory Effects

, 1(2): 135 - 156

Fan Jiang and Gregory J. Dusting


DOI: 10.2174/1570161033476736




Platelet Activation, Inflammatory Mediators and Hypercholesterolemia

, 1(2): 157 - 169

Patrizia Ferroni, Stefania Basili and Giovanni Davi


DOI: 10.2174/1570161033476772




Clinical Value of Prostacyclin and its Analogs in the Management of Pulmonary Arterial Hypertension

, 1(2): 171 - 181

Michael Dandel and Roland Hetzer


DOI: 10.2174/1570161033476754




Vulnerable Atherosclerotic Plaque: Clinical Implications

, 1(2): 183 - 204

Jinho Shin, Jay E. Edelberg and Mun K. Hong


DOI: 10.2174/1570161033476727




Treatment of Chronic Peripheral Arterial Disease

, 1(2): 205 - 216

P. L. Antignani


DOI: 10.2174/1570161033476691




A Novel Therapeutic Strategy Against Vascular Disorders with Chymase Inhibitor

, 1(2): 217 - 224

Shinji Takai and Mizuo Miyazaki


DOI: 10.2174/1570161033476709




Diabetes, the Renin-Angiotensin System and Heart Disease

, 1(2): 225 - 238

Hoong Sern Lim and Gregory Y.H. Lip


DOI: 10.2174/1570161033476682




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science